Jurgen Kuball

Full Professor

Strategic program(s):

Biography

Prof. Dr. Jürgen Kuball is Chair of the Department of Hematology, and Director of the Bone Marrow Transplantation Program at the UMC Utrecht Cancer Centre. His research activities focus on tumor immunology and the ATMP development of a next generation of engineered immune cells, with an emphasis on the therapeutic potential of individual receptors derived from γδT cells. His clinical activities focus around acute leukemia and allogeneic stem cell transplantation. He is an active member of European Society for Blood and Marrow Transplantation (EBMT), and has chaired the Legal Regulatory Affairs Committee of the EBMT since 2019.

Dr. Kuball received his medical degree in Hematology at the University of Mainz, Germany, and completed his post-doctoral fellowship at the Fred Hutchinson Cancer Center in Seattle, WA, USA. He joined the Department of Hematology at the UMC Utrecht in 2007 as a hematologist and immunologist. In 2010, he became a VIDI-laureate, and the chair of the Applied & Tumor-Immunology section within the Laboratory of Translation Immunology. He has chaired the Department of Hematology (adults) since 2013.

For more information on experimental and translational research please visit Kuball Laboratories

Strategic program(s):

Contact

jkuball@umcutrecht.nl

Pure profile

Research groups

Tumor Immunology

Research aim

Our research aims to revolutionise cancer treatment by advancing innovative immunotherapies, ensuring safer, more effective therapies, and improving patient outcomes, ultimately transforming lives through cutting-edge translational cancer research.

Go to group

Recent publications

All publications

Daratumumab for PRCA after HCT Nico Gagelmann, Moniek de Witte, Christophe Peczynski, William Boreland, Annoek E C Broers, Edgar Jost, Alexander Kulagin, Albert Esquirol, Simona Sica, Jürgen Kuball, Gerardo Errico, Wolfgang Bethge, Johan Maertens, Friedrich Stölzel, Edouard Forcade, Matthew Collin, Matteo Parma, Goda Choi, Nicolaus Kröger, Maria Chiara Di Chio, Maria Chiara Finazzi, Lucia López Corral, Jose Rifón, Alberto Mussetti, Adrian Bloor, Marco Ladetto, Hélène Schoemans, Olaf Penack, Ivan Moiseev, Zinaida Peric
Blood cancer journal, 2025, vol. 15, p.1-8

Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe Nicole Santoro, Christoph Schmid, Moniek de Witte, Mieke W H Roeven, Victoria Potter, Deborah Richardson, Thomas Schroeder, Veronika Válková, Katherine Clesham, Sandrine Loron, Jakob Passweg, Caroline Besley, Bernd Gruhn, Jorinde D Hoogenboom, Jarl E Mooyaart, Isabel Sanchez-Ortega, Simona Pagliuca, Federico Simonetta, Giorgia Battipaglia, Thierry Guillaume, Mette D Hazenberg, Florent Malard, Jürgen Kuball, Annalisa Ruggeri
Bone Marrow Transplantation, 2025, vol. 60, p.697-701

Improved GVHD-free and relapse-free survival after ex vivo αβTCR and CD19 depleted allogeneic HSCT compared to T cell replete HSCT A H G Stuut, C Nijssen, L van der Wagen, A van Rhenen, L G M Daenen, A Janssen, F A Verheij, I Brinkman, F M Verduyn Lunel, H Koene, R Fijnheer, H J Prins, K Westinga, J Drylewicz, J Kuball, M A de Witte
Bone Marrow Transplantation, 2025, vol. 60, p.673-681

The use of MSCs in steroid-refractory acute GvHD in Europe L G M Daenen, L E van der Wagen, E F Bonneville, L López-Corral, A Bukauskas, M Bornhäuser, Y Beguin, M Itäla-Remes, J D Hoogenboom, L C de Wreede, F Malard, C Chabannon, F Dazzi, A Ruggeri, J Kuball
Bone Marrow Transplantation, 2025, vol. 60, p.708-714

Definitions matter Konradin F. Müskens, Winny N.R. Collot-d'Escury, Rana Dandis, Saskia Haitjema, Jürgen Kuball, Moniek A. de Witte, Marc Bierings, Caroline A. Lindemans, Stefan Nierkens, Mirjam E. Belderbos
Hemasphere, 2024, vol. 8

Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation Annoek E C Broers, Ellen Meijer, Bronno van der Holt, Cornelis N de Jong, Erfan Nur, Geerte L van Sluis, Goda Choi, Michel van Gelder, Johan A Maertens, Jürgen Kuball, Dries Deeren, Heleen A Visser-Wisselaar, Lamberdina A H M Meulendijks, Jan J Cornelissen,
Hemasphere, 2024, vol. 8

Fellowships & Awards

American Association of Cancer Research-GlaxoSmithKline Scholar in Cancer Research Award (2001)
Stipendiat der Deutschen Krebshilfe (2005-2007)
Team Science recognition award of the „Society for Immunotherapy of Cancer“ to Jürgen Kuball and the University of Washington, USA (2010)
VIDI-Laureate ZonMW, The Netherlands (2010)

External positions

aandeelhouder - shareholder via Gadeta Founders - Century Therapeutics & Adeta

Chair - Chairing - Immunology Community Life Science

Secretary team member - bestuurslid - GoCART Coalition (EBMT/EHA)

Inkomsten licentie - Onderzoek - UMCU Holding

Commissie lid PPS commissie - grant indieningen voor KWF beoordelen - KWF

aandeelhouder - Receiving revenues from licensed patents via UMCU - UMC Holding

Chair legal and rgulatory affairs committee - Chair - EBMT

grant - grant ontvangen voor onderzoek - Novartis

Onderzoeker - grant ontvangen voor onderzoek - Miltenyi

bestuurslid - member general Board - HOVON

Patent holder multipe inventions licensed to Gadeta-follow up company Century Therapeuitcs &Miltenyi - Patent houder - Various